Beta Bionics, Inc. (BBNX) PT Raised to $33 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst David Roman raised the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $33.00 (from $26.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
